These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36959453)

  • 1. Modeling of SARS-CoV-2 Virus Proteins: Implications on Its Proteome.
    Sarkar M; Saha S
    Methods Mol Biol; 2023; 2627():265-299. PubMed ID: 36959453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.
    Gupta R; Charron J; Stenger CL; Painter J; Steward H; Cook TW; Faber W; Frisch A; Lind E; Bauss J; Li X; Sirpilla O; Soehnlen X; Underwood A; Hinds D; Morris M; Lamb N; Carcillo JA; Bupp C; Uhal BD; Rajasekaran S; Prokop JW
    J Biol Chem; 2020 Aug; 295(33):11742-11753. PubMed ID: 32587094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
    Ong E; Wong MU; Huffman A; He Y
    Front Immunol; 2020; 11():1581. PubMed ID: 32719684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
    Giri R; Bhardwaj T; Shegane M; Gehi BR; Kumar P; Gadhave K; Oldfield CJ; Uversky VN
    Cell Mol Life Sci; 2021 Feb; 78(4):1655-1688. PubMed ID: 32712910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and druggability analysis of the SARS-CoV-2 proteome.
    Cavasotto CN; Lamas MS; Maggini J
    Eur J Pharmacol; 2021 Jan; 890():173705. PubMed ID: 33137330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
    J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.
    Alsulami AF; Thomas SE; Jamasb AR; Beaudoin CA; Moghul I; Bannerman B; Copoiu L; Vedithi SC; Torres P; Blundell TL
    Brief Bioinform; 2021 Mar; 22(2):769-780. PubMed ID: 33416848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
    Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
    J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronaviruses: What Should We Know About the Characteristics of Viruses?
    Ji W
    Adv Exp Med Biol; 2021; 1318():23-39. PubMed ID: 33973170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Elrashdy F; Redwan EM; Uversky VN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
    Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
    J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.